← FDA Drug Approvals (Drugs@FDA)
LIVMARLI
NDA · New Drug Application · Sponsor: MIRUM · Approved 2025-04-10
Drug application
- FDA Application #
NDA219485- Application type
- New Drug Application
- Brand name
- LIVMARLI
- Generic name
- MARALIXIBAT CHLORIDE
- Active ingredients
- MARALIXIBAT CHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- MIRUM
- Manufacturer
- Mirum Pharmaceuticals Inc.
- First approval
- 2025-04-10
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown